NEWSROOM

NASDAQ

Creative Medical Technology Granted FDA Clearance for Chronic Back Pain Clinical Trial

Creative Medical Technology Granted FDA Clearance for Chronic Back Pain Clinical Trial

Dec 21, 2023

New York, December 21, 2023 - Creative Medical Technology Holdings, Inc. (Nasdaq: CELZ) has received FDA clearance to conduct a phase 1/2 clinical trial using the company’s innovative StemSpine® treatment known as AlloStem™ (CELZ-201-DDT). https://prismmarketview.com/companies/creative-medical-technology-holdings-inc/ Timothy Warbington, CEO of Creative Medical Technology, said, “The FDA’s clearance and IRB approval allowing us to pursue this clinical trial is another...

PRISM BIOTECH IN MOTION: FDA APPROVAL FOR PANBELA THERAPEUTICS PEDIATRIC CANCER DRUG; SHARES JUMP 120%

PRISM BIOTECH IN MOTION: FDA APPROVAL FOR PANBELA THERAPEUTICS PEDIATRIC CANCER DRUG; SHARES JUMP 120%

Dec 20, 2023

New York, December 20, 2023 - PRISM MarketView, a leading provider of unbiased market insight and company news, today highlights Panbela Therapeutics, Inc. which has announced that US WorldMeds®1 (USWM) has received FDA approval of its New Drug Application (NDA) for the use of eflornithine as a maintenance therapy for high-risk neuroblastoma patients. In July 2023, Panbela divested its pediatric neuroblastoma program to USWM in an arrangement entitling Panbela to up to approximately $9.5...

PRISM MarketView: Biotech In Motion – Lipella Pharmaceuticals Celebrates Year of Success

PRISM MarketView: Biotech In Motion – Lipella Pharmaceuticals Celebrates Year of Success

Dec 20, 2023

New York, December 20, 2023 - Clinical-stage biotechnology company, Lipella Pharmaceuticals (Nasdaq: LIPO) is celebrating a year of strategic accomplishments on its first anniversary as a public company. Lipella is advancing three clinical indications and has been granted two Orphan Drug Designations by the US Food and Drug Administration (FDA). https://prismmarketview.com/companies/lipella-pharmaceuticals-inc/ Today, the company announced it has successfully completed a Type C meeting with...

Buy Now, Pay Later: Affirm Shares Jump on News of Walmart Partnership

Buy Now, Pay Later: Affirm Shares Jump on News of Walmart Partnership

Dec 20, 2023

New York, December 20, 2023 - Shares in payment network company, Affirm Holdings (Nasdaq: AFRM), jumped more than 15% on Tuesday after the company announced it would expand its partnership with Walmart to offer a Buy Now, Pay Later (BNPL) service at self-checkout kiosks at over 4,500 Walmart stores in the United States. https://prismmarketview.com/companies/affirm-holdings-inc/ https://prismmarketview.com/buy-now-pay-later-affirm-shares-jump-on-news-of-walmart-partnership/ Pat Suh, Affirm’s...

Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplished

Dec 20, 2023

-Lipella Granted Two Orphan Drug Designations by FDA- Pittsburgh, PA, December 20, 2023 - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) ("Lipella," "our," "us" or the "Company") a pioneering, clinical-stage pharmaceutical company, celebrates its first anniversary as a publicly traded entity. Based in Pittsburgh, PA, the Company has made substantial strides over the past year, achieving critical milestones and advancing its pipeline with three clinical indications and two orphan drug designations...

NRx Pharmaceuticals Secures IND for Urinary Tract Infection Treatment

NRx Pharmaceuticals Secures IND for Urinary Tract Infection Treatment

Dec 19, 2023

New York, December 19, 2023 - NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) has been granted FDA clearance for its Investigational New Drug Application (IND) for NRX-101 for the treatment of complicated Urinary Tract infections (cUTI). The company’s shares surged 25% in trading on Monday following the news. https://prismmarketview.com/companies/nrx-pharmaceuticals-inc/ Complicated Urinary Tract Infections afflict approximately 3 million Americans each year, and pathogens have...

PRISM Analysis: Why Did Battalion Oil Shares Soar on Friday?

PRISM Analysis: Why Did Battalion Oil Shares Soar on Friday?

Dec 18, 2023

NEW YORK, NY, December 18, 2023 - Shares in Battalion Oil Corporation (NYSE American: BATL) surged more than 80% on Friday after the company announced it has agreed to be acquired by Fury Resources, Inc. for $9.80 per share in cash, which represents a total transaction value of approximately $450 million. The transaction is expected to close in the first quarter of 2024. https://prismmarketview.com/companies/trio-petroleum-corp/ Battalion’s CEO, Matt Steele, commented, “It has been a pleasure...

MindMed Advances Treatment for Generalized Anxiety Disorder

MindMed Advances Treatment for Generalized Anxiety Disorder

Dec 18, 2023

NEW YORK, NY, December 18, 2023 - Biopharmaceutical company, Mind Medicine (Nasdaq: MNMD) has announced positive results from its Phase 2b clinical trial of MM-120 (lysergide d-tartrate) in generalized anxiety disorder (GAD). The trial met its primary endpoint, with MM-120 demonstrating statistically significant and clinically meaningful dose-dependent improvements. https://prismmarketview.com/companies/mind-medicine-mindmed-inc/ Robert Barrow, Chief Executive Officer and Director of MindMed,...

PRISM AdTech & Media Company Spotlight: Creative Realities Illuminates the Future of Experiential Design

PRISM AdTech & Media Company Spotlight: Creative Realities Illuminates the Future of Experiential Design

Dec 16, 2023

In the fast-paced landscape of experiential design and technology, Creative Realities Inc. seamlessly integrates the physical and digital realms in creating immersive experiences that captivate audiences across various industries. NEW YORK, NY, December 16, 2023 - Creative Realities specializes in interactive displays, immersive retail solutions, and cutting-edge content creation to reshape how individuals connect with brands and spaces. With a commitment to innovation and a client-centric...

PRISM MediaWire – Weekly Press Resume – Dec. 11 to Dec. 15, 2023

PRISM MediaWire – Weekly Press Resume – Dec. 11 to Dec. 15, 2023

Dec 15, 2023

New York, December 15, 2023 PRISM MediaWire - Weekly Press Resume Dec. 11 to Dec. 15, 2023 UAT Group Receives Financing for Iron Removal System https://prismmediawire.com/uat-group-receives-financing-for-iron-removal-system/ SKYX and GE Sign a Five-Year Renewal of a Global Licensing Master Service Agreement as SKYX Continues to Enhance its Market Penetration and Collaborations with U.S. and World Leading Strategic Companies...

“Exceptional Result”: NeuroSense Therapeutics Reports New Positive Data from ALS Trial

“Exceptional Result”: NeuroSense Therapeutics Reports New Positive Data from ALS Trial

Dec 15, 2023

NEW YORK, NY, December 15, 2023 - NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) has reported additional positive efficacy data from its Phase 2b trial evaluating PrimeC, the company’s lead drug candidate for amyotrophic lateral sclerosis (ALS). The company’s share price rose nearly 30% in trading on Thursday. https://prismmarketview.com/companies/neurosense-therapeutics-ltd/ Alon Ben-Noon, NeuroSense’s CEO, commented, “As we analyze the PARADIGM trial results, we continue to gain a better...

PRISM AdTech & Media Company Spotlight: Creative Realities Illuminates the Future of Experiential Design

PRISM AdTech & Media Company Spotlight: Creative Realities (CREX) Illuminates the Future of Experiential Design

Dec 14, 2023

NEW YORK, NY, December 14, 2023 - In the fast-paced landscape of experiential design and technology, Creative Realities Inc. ($CREX) seamlessly integrates the physical and digital realms in creating immersive experiences that captivate audiences across various industries. From transforming retail spaces into dynamic environments to utilizing cutting-edge technologies in interactive displays, CREX is reshaping the way we interact with the world....

Sono-Tek Announces Preliminary Record Revenue with Continued Strong Backlog for Q3 FY2024 and Increases Revenue Guidance for Fiscal Year 2024

Sono-Tek Announces Preliminary Record Revenue with Continued Strong Backlog for Q3 FY2024 and Increases Revenue Guidance for Fiscal Year 2024

Dec 14, 2023

- Sales Grew 58% YOY; Backlog Grew 68% YOY and Remains Strong at $10.4 Million; Company Projects 30% Revenue Growth for Fiscal Year ending February 29, 2024- MILTON, NY, December 14, 2023 – Sono-Tek Corporation (NASDAQ: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced preliminary sales and backlog for the third quarter of fiscal year 2024, ended November 30, 2023. • Preliminary sales for the third quarter of FY2024 were...

PRISM Oil & Gas: S&P Sets Fresh YTD High; Falling Gasoline Prices Play Key Role in Cooling Inflation

PRISM Oil & Gas: S&P Sets Fresh YTD High; Falling Gasoline Prices Play Key Role in Cooling Inflation

Dec 13, 2023

NEW YORK, NY, December 13, 2023 - US equities closed mostly higher on Tuesday as the S&P set a fresh year-to-date high, finishing the day at its highest level since January 2022, just 3.2% below its all-time high. Energy stocks underperformed while gasoline prices were down (6%) for the month, playing a key role in cooling inflation numbers for November. The S&P 500 Energy Index was down (1.35%) versus the S&P 500 which rose +0.14%. The XLE settled down (1.39%), the XOP fell...

FDA Grants PMA Supplement Approval for ReShape Lifesciences Lap Band; Shares Surge 100%

FDA Grants PMA Supplement Approval for ReShape Lifesciences Lap Band; Shares Surge 100%

Dec 13, 2023

NEW YORK, NY, December 13, 2023 - ReShape Lifesciences (Nasdaq: RSLS) has been granted FDA approval of a PMA supplement for the company’s next generation, enhanced Lap-Band® 2.0 FLEX. The company’s share price surged 100% in trading on Wednesday morning. https://prismmarketview.com/companies/reshape-lifesciences-inc/ Paul F. Hickey, President and Chief Executive Officer of ReShape Lifesciences, said, “PMA supplement approval for our next generation Lap-Band® 2.0 FLEX is a...

PRISM MarketView Biotech in Motion Spotlight: Quoin Receives FDA Clearance for Netherton Syndrome Clinical Optimization Plan

PRISM MarketView Biotech in Motion Spotlight: Quoin Receives FDA Clearance for Netherton Syndrome Clinical Optimization Plan

Dec 13, 2023

NEW YORK, NY, December 13, 2023 - Quoin Pharmaceuticals (Nasdaq: QNRX) has received U.S. Food and Drug Administration (FDA) clearance to implement several protocol amendments to its two ongoing clinical trials for QRX003, which is a potential treatment for Netherton Syndrome, a rare genetic skin disease for which there is no cure and no approved treatments. These protocol amendments are being implemented with a view to generating an even more robust data set and potentially more...

PRISM NEXT GEN TECH COMPANY SPOTLIGHT: THE GLIMPSE GROUP’S JOURNEY INTO THE FUTURE

Dec 12, 2023

NEW YORK, NY, December 12, 2023 - An immersive technology platform company, Glimpse recently announced its plans for a strategic shift from current immersive technologies that include virtual-reality headsets, tablets and phones to spatial computing, cloud and AI-driven immersive software solutions. From cutting-edge software development to immersive content creation, Glimpse pushes the boundaries of what is possible in the realm of extended realities....

PRISM MarketView Launches Emerging AdTech and Media Index

Dec 12, 2023

Leading global companies work to strike balance between digital and traditional advertising Industry experts point to 2H 2024 for AdTech and Media IPO market to strengthen NEW YORK, NY, December 12, 2023 - PRISM MarketView, a leading provider of unbiased market insight and company news, today announces the launch of its PRISM Emerging AdTech and Media Index. With a finger on the pulse of the digital media revolution, the PRISM index is tracking emerging companies making a mark on the adtech...

MyMD Tackles Rheumatoid Arthritis with Launch of Phase 2 Trial in Early 2024

MyMD Tackles Rheumatoid Arthritis with Launch of Phase 2 Trial in Early 2024

Dec 11, 2023

NEW YORK, NY, December 11, 2023 - The FDA has cleared an Investigational New Drug Application (IND) for MyMD Pharmaceuticals (Nasdaq: MYMD) to initiate a Phase 2 clinical trial of oral MYMD-1® as a treatment for rheumatoid arthritis (RA). The company plans to launch the trial in the first quarter of 2024. Chris Chapman, M.D., president, director, and chief medical officer of MyMD Pharmaceuticals, said, “With the FDA’s recent clearance of our IND in RA, we are moving forward with plans to...

SKYX and GE Sign a Five-Year Renewal of a Global Licensing Master Service Agreement as SKYX Continues to Enhance its Market Penetration and Collaborations with U.S. and World Leading Strategic Companies

Dec 11, 2023

MIAMI, FL, December 11, 2023 - SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the "Company" or "SKYX"), a highly disruptive platform technology company with 77 pending and issued patents globally and over 60 lighting and home décor websites, with a mission to make homes and buildings become safe and smart as the new standard, today announced that it has signed with GE Technology Development, Inc. ("GE") a five-year renewal of a global licensing master service agreement to...

PRISM MediaWire – Weekly Press Resume – Dec. 04 to Dec. 08, 2023

PRISM MediaWire – Weekly Press Resume – Dec. 04 to Dec. 08, 2023

Dec 8, 2023

New York, December 08 , 2023 PRISM MediaWire - Weekly Press Resume Dec 04 to Dec. 08, 2023 Xcyte Digital Produces Second Metaverse Spectrum Business Conference and Launches Inaugural Pitch Fest https://prismmediawire.com/xcyte-digital-produces-second-metaverse-spectrum-business-conference-and-launches-inaugural-pitch-fest/ Peer To Peer Network Announces It Has Hired A PR Firm. Set To Start Major Public Relations Operation Starting In 2024...

PRISM Analysis: Stocks Making the Biggest Moves in Thursday Trading

Dec 7, 2023

NEW YORK, NY, December 07, 2023 - US equities are settling mostly higher in Thursday midday trading, with big tech broadly higher as Google ($GOOG) rallies after the company’s launch of Project Gemini, an AI model trained to behave in human-like ways. Airlines, including JetBlue ($JBLU), credit cards and chemicals are performing well. https://prismmarketview.com/prism-analysis-stocks-making-the-biggest-moves-in-thursday-trading/ Notable gainers for the day include Verint Systems ($VRNT) which...

PRISM Next Gen Tech Company Spotlight: The Glimpse Group’s Journey into the Future

Dec 7, 2023

NEW YORK, NY, December 07, 2023 - In the ever-evolving landscape of technological innovation, the Glimpse Group, Inc. (VRAR) emerges as a beacon of creativity and ingenuity, weaving a future where virtual and augmented realities seamlessly blend with our daily lives. Glimpse, combines reality with the extraordinary, allowing for the future to become a tangible reality. https://prismmarketview.com/companies/the-glimpse-group/ Company Snapshot: A Glimpse into Glimpse Group At the heart of...

PRISM MarketView Biotech Index Top Mover Spotlight: Kamada (KMDA)

Dec 7, 2023

NEW YORK, NY, December 07, 2023 - PRISM MarketView, a leading provider of unbiased market insight and company news, highlights Kamada Ltd. (Nasdaq: KMDA), a commercial-stage global biopharmaceutical company with a portfolio of products for rare and serious conditions and a leader in the specialty plasma-derived field, today announced it has inked its largest commercial agreement to date, set to take effect in January 2024. https://prismmarketview.com/companies/kamada-ltd/...

Oncocyte Begins FDA Submissions Process for VitaGraft Transplant Assays

Dec 6, 2023

Significant unmet need for regulated product in $2B US testing market Opportunity for expedited pathway for kitted product in development IRVINE, CA, December 06, 2023 - Oncocyte Corporation (NASDAQ:OCX), a precision diagnostics company, today announced it has begun the FDA single-site process for its VitaGraft transplant assays. The single-site process is a well-established pathway for Lab Developed Tests (LDTs) to seek regulatory approval. This move positions Oncocyte within the recent...

PRISM MARKETVIEW HIGHLIGHTS ALTIMMUNE’S POSITIVE TOPLINE RESULTS IN OBESITY DRUG TRIAL

Dec 5, 2023

NEW YORK, NY, December 05, 2023 - PRISM MarketView, a leading provider of unbiased market insight and company news, highlights Altimmune, Inc. (Nasdaq: ALT) which has reported positive topline results from its 48-week MOMENTUM Phase 2 obesity trial of pemvidutide. https://prismmarketview.com/companies/altimmune-inc/ The company’s study enrolled 391 subjects with obesity and at least one comorbidity. Over 50% of subjects achieved at least 15% weight loss and over 30% of subjects achieved at...

PRISM MediaWire – Weekly Press Resume – Nov. 27 to Dec. 01, 2023

PRISM MediaWire – Weekly Press Resume – Nov. 27 to Dec. 01, 2023

Dec 1, 2023

New York, December 1, 2023 PRISM MediaWire - Weekly Press Resume Nov. 27 to Dec. 01, 2023 Two Hands Corporation: Elevating Canada's Micro Merchant Wholesaler Landscape https://prismmediawire.com/two-hands-corporation-elevating-canadas-micro-merchant-wholesaler-landscape/ Metatron’s FanFinder: Enhanced Engagement and Audience Discovery for TikTok and OnlyFans https://prismmediawire.com/metatrons-fanfinder-enhanced-engagement-and-audience-discovery-for-tik-tok-and-onlyfans/ SS Innovations...

Smart Technology, Smarter Partnership: SKYX and Kichler Collaborate on Next-Gen, High-End Lighting

Nov 30, 2023

MIAMI, FL, November 30, 2023 - SKYX Platforms Corp (SKYX) is a leading innovator emerging in the next generation of lighting through the creation of its Advanced and Smart Plug & Play Technology products. The company has been growing its footprint in the lighting/ceiling fan space and recently announced a new product collaboration with Kichler. With 85 years of success, Kichler is one of the most respected lighting and ceiling fan brands in the world and is a principal supplier...

Federal Reserve “Increasingly Confident” Policy Positioned to Slow Economy, Reduce Inflation; WTI and Brent Rebound from Morning Lows

Nov 28, 2023

NEW YORK, NY, November 28, 2023 - PRISM MarketView, a leading provider of unbiased market insight and company news, today provides its PRISM Emerging Oil & Gas overview. US equities were narrowly mixed in Tuesday afternoon trading as November consumer confidence increased to 102 on the index, ahead of economists’ expectations. The S&P 500 Energy Index was up +0.85% versus the S&P 500 which rose +0.33%. The XLE settled at +0.82% while the XOP rose by +0.77%. The day’s PRISM Oil...

Two Hands Corporation: Elevating Canada’s Micro Merchant Wholesaler Landscape

Two Hands Corporation: Elevating Canada’s Micro Merchant Wholesaler Landscape

Nov 27, 2023

TORONTO, ON, November 27, 2023 – Two Hands Corporation (CSE: TWOH) (OTC: TWOH), a leader in the Canadian food industry, proudly announces a significant initiative to revolutionize the micro food merchant wholesaler sector. This strategy involves consolidating vulnerable micro food merchant wholesalers and equipping them with comprehensive infrastructure, including warehousing, distribution, logistics, digital solutions, and inventory financing. This initiative targets over 2600 micro merchant...